ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

ClinicalTrials.gov ID: NCT02200042

Public ClinicalTrials.gov record NCT02200042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma

Study identification

NCT ID
NCT02200042
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
NRG Oncology
Other
Enrollment
1 participant

Conditions and interventions

Interventions

  • Image Guided Radiation Therapy Radiation

Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2014
Primary completion
Jul 1, 2018
Completion
Jul 1, 2018
Last update posted
May 18, 2026

2014 – 2018

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
28
Facility City State ZIP Site status
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Sutter Medical Center Sacramento Sacramento California 95816
Emory University Hospital Midtown Atlanta Georgia 30308
Piedmont Hospital Atlanta Georgia 30309
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
Queen's Medical Center Honolulu Hawaii 96813
Northwestern University Chicago Illinois 60611
Decatur Memorial Hospital Decatur Illinois 62526
Loyola University Medical Center Maywood Illinois 60153
OSF Saint Francis Medical Center Peoria Illinois 61637
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
Maryland Proton Treatment Center Baltimore Maryland 21201
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Boston Medical Center Boston Massachusetts 02118
Lahey Hospital and Medical Center Burlington Massachusetts 01805
Washington University School of Medicine St Louis Missouri 63110
Missouri Baptist Medical Center St Louis Missouri 63131
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon New Hampshire 03756
University of New Mexico Cancer Center Albuquerque New Mexico 87106
Mount Sinai Hospital New York New York 10029
University of Rochester Rochester New York 14642
University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio 45219
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Legacy Good Samaritan Hospital and Medical Center Portland Oregon 97210
M D Anderson Cancer Center Houston Texas 77030
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112
University of Vermont Medical Center Burlington Vermont 05401
FHCC Proton Therapy Center Seattle Washington 98133
University of Washington Medical Center - Montlake Seattle Washington 98195
West Virginia University Healthcare Morgantown West Virginia 26506
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02200042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2026 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02200042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →